Zitiert in 5+ Publikationen.
Der Ratte Monoklonal anti-Smad1 , Smad8 Antikörper (Klon N6-1233) (ABIN1177176) detektiert spezifisch Smad1 , Smad8 in ICS, IHC und WB.
Dieser Antikörper reagiert spezifisch mit Proben aus Human und Maus.
Reaktivität: Human, Maus
ICS
Wirt: Ratte
Monoclonal
N6-1233
PE
Protokoll
In human PBMC, overnight serum starvation was found to be necessary for detection of a BMP-6-induced increase in Smad1/8 phosphorylation. Serum starvation for 1 hour following PBMC isolation was not sufficient to reduce basal levels of Smad1 (pS463/pS465)/Smad8(pS465/pS467). Some donor variation was observed in the reduction of basal phosphorylation by overnight serum starvation.
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C
Informationen zur Lagerung
Store undiluted at 4°C.
Whitman: "Smads and early developmental signaling by the TGFbeta superfamily." in: Genes & development, Vol. 12, Issue 16, pp. 2445-62, (1998) (PubMed).
Kretzschmar, Doody, Massagué: "Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1." in: Nature, Vol. 389, Issue 6651, pp. 618-22, (1997) (PubMed).
Kretzschmar, Liu, Hata, Doody, Massagué: "The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase." in: Genes & development, Vol. 11, Issue 8, pp. 984-95, (1997) (PubMed).
Hoodless, Haerry, Abdollah, Stapleton, OConnor, Attisano, Wrana: "MADR1, a MAD-related protein that functions in BMP2 signaling pathways." in: Cell, Vol. 85, Issue 4, pp. 489-500, (1996) (PubMed).
Target
Smad1 , Smad8
Hintergrund
The N6-1233 monoclonal antibody specifically binds to the Smad1 protein phosphorylated at the Ser463/465 sites and the Smad8 protein phosphorylated at the Ser465/467 sites. Smad1 and Smad8 are ~60 kDa proteins and are members of the Smad superfamily. The Smad family members are divided into three subfamilies: receptor regulated Smads or R-Smads, including Smads1, 2, 3, 5, and 8, common partner Smad, or Co-Smad, including Smad4, and inhibitory Smads, or I-Smad, including Smads 6 and 7. Activation of Transforming Growth Factor-beta (TGF-beta) superfamily serine/threonine kinase receptors, such as TGF-beta and Bone Morphogenic Protein (BMP) receptors, leads to the phosphorylation of R-Smads at several sites. It has been shown that Ser463 and Ser465 of Smad1 are phosphorylated by BMP receptors. In B cells and pre-B cells, BMP-6 has been shown to induce Smad1/5/8 phosphorylation and inhibit cell proliferation. Phosphorylated R-Smads form complexes with Co-Smad and translocate into the nucleus to regulate transcription affecting a wide range of critical processes including cell-fate determination, proliferation, morphogenesis, differentiation and apoptosis. The inhibitory Smads inhibit this pathway through two potential mechanisms: either by preventing R-Smads from binding to their corresponding receptors and/or by competing with Smad4, the Co-Smad, from binding to R-Smads. This antibody may crossreact with Smad5 pS463/pS465 based on sequence homology. Synonyms: Smad1,Smad8/Smad9, MADH1, MADH9